Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions

Dow, S&P 500, Nasdaq Futures Climb As Treasury Yields Pull Back: MRNA, BULL, MSTR, NVAX Stocks In Focus

Figure's Take Rate Is Shrinking By Design

Reddit (RDDT) Jumped 13% on S&P 500 Inclusion. Will Index Demand Hold the Gain?